Neurocrine Biosciences, Inc.
NBIX institutional ownership changes in Q2 2026: 168 institutions opened or added positions, 117 trimmed or exited. NBIX (Neurocrine Biosciences, Inc.) is held by 279 institutional investors as of Q2 2026. Top institutional shareholders: BlackRock, Inc. ($2.3B), JPMorgan Chase & Co. ($1.1B), Dodge & Cox ($941.2M). Net institutional sentiment: Mixed.
Who's Trading
Latest move
Source dates: Price Nov 5, 2026 · Insiders Nov 3, 2026 · Activists Oct 30, 2026 · Congress Aug 13, 2025
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
Increased | 13.7M(+2.4%) | $2.3B | 0.0% | +39.58% | 33 | |
Increased | 6.4M(+17.6%) | $1.1B | 0.1% | +27.52% | 37 | |
Increased | 5.6M(+2.3%) | $941.2M | 0.5% | +33.05% | 39 | |
Increased | 5M(+5.2%) | $838.3M | 0.0% | +23.42% | 33 | |
Increased | 4.5M(+0.7%) | $766M | 0.0% | +24.88% | 32 | |
Increased | 4.4M(+0.7%) | $739.1M | 0.0% | +57.34% | 32 | |
Decreased | 3.8M(-22.7%) | $643.5M | 0.2% | +24.65% | 0 | |
Decreased | 2.3M(-3.4%) | $393.7M | 0.5% | +39.67% | 0 | |
Increased | 2.1M(+0.1%) | $359.6M | 0.0% | +69.79% | 31 | |
Decreased | 2.1M(-32.2%) | $349.9M | 0.3% | +22.27% | 0 | |
Increased | 1.5M(+0.0%) | $251.9M | 0.3% | +38.35% | 37 | |
Increased | 1.3M(+8.2%) | $222.2M | 0.0% | +19.44% | 33 | |
Increased | 1.3M(+19.4%) | $213.7M | 1.8% | +24.28% | 57 | |
Increased | 1.3M(+1.4%) | $212.3M | 0.0% | +40.17% | 31 | |
Increased | 1.1M(+202.6%) | $181.6M | 0.0% | +5.63% | 49 | |
Increased | 974,279(+7.9%) | $164.2M | 0.0% | +58.26% | 33 | |
Decreased | 923,125(-3.8%) | $155.6M | 0.1% | +34.69% | 0 | |
Increased | 732,877(+3.0%) | $123.5M | 0.0% | +43.96% | 31 | |
Increased | 726,112(+39.6%) | $122.4M | 0.4% | +16.83% | 48 | |
Decreased | 699,125(-0.5%) | $117.8M | 0.0% | +69.81% | 0 |
Showing 1-20 of 291
NBIXNeurocrine Biosciences, Inc.Continue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about NBIX
Who owns NBIX?
279 institutional investors held NBIX on June 30, 2026, led by BlackRock, Inc. ($2.3B), JPMorgan Chase & Co. ($1.1B) and Dodge & Cox ($941.2M).
How many hedge funds hold NBIX?
279 institutional investors reported NBIX in their 13F filings for the quarter ended June 30, 2026, $15.2B in all. 13 of them are rated Elite.
Are institutions buying or selling NBIX?
Buying, on balance. In Q2 2026, 168 institutions opened or added to positions in NBIX and 117 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer